Free Newsletter
Flu jab missing the mark in seasonal campaign
There's growing evidence around the U.S. that the flu jab offers only marginal protection against the seasonal ailment. In Texas, doctors say this year's flu vaccine guarded against less than 30 percent of all flu viruses. The vaccine, which is revised every year to make it as effective as possible, usually works against 70 percent to 90 percent of all the viruses in circulation. Across the country, physicians are reporting an efficacy rate of around 50 percent. Lower response rates are likely to generate a large crop of misery.
"If this vaccine is not working as well as we'd hoped, it has the makings of being one of the worst years for flu," Dr. R. Doug Hardy, infectious disease specialist at Children's Medical Center Dallas and UT Southwestern Medical Center, told the Dallas Morning News.
- read the report in The Dallas Morning News
ALSO: WHO is recommending a whole new flu vaccine for next season after seeing the virus mutate unexpectedly. Report
PLUS: And the FDA brought together a large group of flu specialists this week to do just that. Report
Related Articles:
Vaccines miss their mark in seasonal flu campaign. Report
Universal flu vaccine shows early promise. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




